BPC-157 (Body Protection Compound-157) 20 mg is a synthetic peptide derived from a naturally occurring protein found in gastric juice. It is widely recognized in scientific and research communities for its stability and targeted biological activity. Read More
Dosage Strength:
20 Mg
Full Name:
Body Protection Compound-157
Peptide Type:
Synthetic Pentadecapeptide
Amino Acid Length:
15 Amino Acids
BPC-157 (Body Protection Compound-157) 20 mg is a synthetic peptide derived from a naturally occurring protein found in gastric juice. It is widely recognized in scientific and research communities for its stability and targeted biological activity. The 20 mg strength is supplied in a lyophilized (freeze-dried) form to ensure purity, potency, and extended shelf life. This peptide is commonly studied for its role in cellular protection and tissue-related research, making it a popular choice in laboratory and investigational settings. BPC-157 is valued for its consistency and reliability when used under controlled, professional conditions.
Key Features
| Dosage Strength | 20 mg |
| Full Name | Body Protection Compound-157 |
| Peptide Type | Synthetic pentadecapeptide |
| Amino Acid Length | 15 amino acids |
| Molecular Formula | C62H98N16O22 |
| Product Category | Regenerative peptide |
| Primary Function | Tissue healing and anti-inflammatory effects |
| Administration | Oral / injection |
| Mechanism Activates | VEGFR2 and angiogenesis pathways |
| Appearance | White crystalline powder |
| Solubility | Water soluble |
| Storage Condition | −20°C recommended |
| Shelf Life | 24 months |
| Target System | Gastrointestinal & musculoskeletal |
| Packaging Material | Sterile vial |
| Origin | Canada |
| Dosage Strength | 20 mg |
| Full Name | Body Protection Compound-157 |
| Peptide Type | Synthetic pentadecapeptide |
| Amino Acid Length | 15 amino acids |
| Molecular Formula | C62H98N16O22 |
| Product Category | Regenerative peptide |
| Primary Function | Tissue healing and anti-inflammatory effects |
| Administration | Oral / injection |
| Mechanism Activates | VEGFR2 and angiogenesis pathways |
| Appearance | White crystalline powder |
| Solubility | Water soluble |
| Storage Condition | −20°C recommended |
| Shelf Life | 24 months |
| Target System | Gastrointestinal & musculoskeletal |
| Packaging Material | Sterile vial |
| Origin | Canada |
3316 E Richert AveFresno, CA 93726, USA
GET DIRECTION